1-10 of 10
Anne Marfaing-Koka
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of Leukemic Stem Cell Persistence in Chronic Myeloid Leukemia (CML) Patients in Complete Molecular Remission Induced by First Line TKI Therapies

Jean-Claude Chomel, PharmD, PhD, Marie Laure Bonnet, Nathalie Sorel, PhD, Ivan Sloma, PharmD, PhD, Alexis Proust, Annelise Bennaceur-Griscelli, MD, PhD, Delphine Rea, MD, PhD, Madalina Uzunov, M.D., Laurence Legros, MD, PhD, Shanti Ame, MD, Anne Marfaing-Koka, Agnès Guerci, MD, Philippe Rousselot, MD, PhD, Ali G Turhan, M.D., PhD
Journal: Blood
Blood (2012) 120 (21): 3726.
https://doi.org/10.1182/blood.V120.21.3726.3726
Published: 2012
Journal Articles

Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine

Clinical Trials & Observations
Raphael Itzykson, Sylvain Thépot, Bruno Quesnel, Francois Dreyfus, Odile Beyne-Rauzy, Pascal Turlure, Norbert Vey, Christian Recher, Caroline Dartigeas, Laurence Legros, Jacques Delaunay, Célia Salanoubat, Sorin Visanica, Aspasia Stamatoullas, Francoise Isnard, Anne Marfaing-Koka, Stephane de Botton, Youcef Chelghoum, Anne-Laure Taksin, Isabelle Plantier, Shanti Ame, Simone Boehrer, Claude Gardin, C. L. Beach, Lionel Adès, Pierre Fenaux, on behalf of the Groupe Francophone des Myelodysplasies (GFM)
Journal: Blood
Blood (2011) 117 (2): 403–411.
https://doi.org/10.1182/blood-2010-06-289280
Published: 2011
Journal Articles

Prolonged Survival without Complete Remission (CR) In AML Patients (Pts) Treated with Azacitidine (AZA)

Raphael Itzykson, Sylvain Thepot, Odile Beyne-Rauzy, Bruno Quesnel, Shanti Ame, MD, Pascal Turlure, Stephanie Harel, Anne Marfaing-Koka, Youcef Chelgoum, Aspasia Stamatoullas, Madalina Uzunov, Norbert Ifrah, Herve Dombret, MD, PhD, Lionel Ades, CL Beach, PharmD, Arlene S. Swern, PhD, Claude Gardin, Pierre Fenaux
Journal: Blood
Blood (2010) 116 (21): 2183.
https://doi.org/10.1182/blood.V116.21.2183.2183
Published: 2010
Journal Articles

A Prognostic Score for Overall Survival (OS) with Azacitidine (AZA) In Higher Risk MDS Based on 282 Patients (pts), and Validated In 175 Pts From the AZA 001 Trial

Raphael Itzykson, Sylvain Thepot, Bruno Quesnel, Francois Dreyfus, Odile Beyne-Rauzy, Pascal Turlure, Christian Recher, Caroline Dartigeas, Norbert Vey, MD, Laurence Legros, Jacques Delaunay, Celia Salanoubat, Sorin Visanica, Aspasia Stamatoullas, Françoise Isnard, MD, Anne Marfaing-Koka, Stephane De Botton, Youcef Chelgoum, Anne-Laure Taksin, Isabelle Plantier, Shanti Ame, Simone Boehrer, Claude Gardin, CL Beach, PharmD, Lionel Ades, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3996.
https://doi.org/10.1182/blood.V116.21.3996.3996
Published: 2010
Journal Articles

Treatment of Advanced CMML by Azacitidine (AZA) In a Compassionate Program. the GFM Experience In 38 Patients (pts)

Alice Wolfromm, Francois Dreyfus, Norbert Vey, Jacques Delaunay, Aspasia Stamatoullas, Anne Banos, MD, Anne Marfaing-Koka, Stephane de Botton, Dominique Bordessoule, Laurence Legros, MD, Odile Beyne Rauzy, Emmanuel Gyan, MD, PhD, Pascale Cony Makhoul, Sylvain Thepot, Raphael Itzykson, Pierre Fenaux, MD, PhD, Lionel Ades
Journal: Blood
Blood (2010) 116 (21): 4023.
https://doi.org/10.1182/blood.V116.21.4023.4023
Published: 2010
Journal Articles

Azacytidine (AZA) in MDS (including RAEB-t and CMML) in Patients (pts) ≥ 80 Years: Results of the French ATU Program.

Raphael Itzykson, Sylvain Thépot, Bechir Achour, Bruno Quesnel, Francois Dreyfus, MD, PhD, Pascal Turlure, MD, Anne-Laure Taksin, MD, Norbert Vey, MD, Anne Marfaing Koka, Stephane de Botton, MD, PhD, Eric Wattel, MD, PhD, Francoise Isnard, Isabelle Plantier, Caroline Dartigeas, Chahinez Zerhouni, Claude Gardin, Lionel Ades, MD, Odile Beyne-Rauzy, MD, PhD, Pierre Fenaux
Journal: Blood
Blood (2009) 114 (22): 1773.
https://doi.org/10.1182/blood.V114.22.1773.1773
Published: 2009
Journal Articles

Azacytidine in Refractory or Relapsed AML After Intensive Chemotherapy (IC): Results of the French ATU Program.

Raphael Itzykson, Sylvain Thépot, Christian Recher, Jacques Delaunay, MD, Bruno Quesnel, Francois Dreyfus, MD, PhD, Anne Marfaing Koka, Norbert Vey, Aspasia Stamatoullas, Emmanuel Gyan, MD, Thomas Cluzeau, Philippe Rousselot, MD, PhD, Oumedaly Reman, Isabelle Plantier, Jean Pierre Marolleau, MD, Pierre Morel, MD, Eric Wattel, MD, PhD, Sorin Visanica, MD, Chahinez Zerhouni, Dominique Bordessoule, Lionel Ades, MD, Pierre Fenaux, Claude Gardin
Journal: Blood
Blood (2009) 114 (22): 1054.
https://doi.org/10.1182/blood.V114.22.1054.1054
Published: 2009
Journal Articles

Azacytidine (AZA) as First Line Therapy in AML: Results of the French ATU Program.

Sylvain Thépot, Raphael Itzykson, Valerie Seegers, Christian Recher, Bruno Quesnel, Jacques Delaunay, MD, Thomas Cluzeau, Anne Marfaing Koka, Aspasia Stamatoullas, MP Chaury, Caroline Dartigeas, Stéphane Cheze, Celia Salanoubat, Pierre Morel, MD, Isabelle Plantier, Anne-Laure Taksin, MD, Jean Pierre Marolleau, MD,, Cecile Pautas, MD, Eric Wattel, MD, PhD, Francoise Isnard, Laurence Sanhes, Stephanie Harel, Stephane de Botton, MD, PhD, Yasmine Chait, Madalina Uzunov, Agnes Guerci, MD, PhD, Mehdi Dahoun, Norbert Vey, MD, PhD,, Herve Dombret, MD, PhD,, Francois Dreyfus, MD, PhD, Lionel Ades, MD,, Pierre Fenaux, Claude Gardin
Journal: Blood
Blood (2009) 114 (22): 843.
https://doi.org/10.1182/blood.V114.22.843.843
Published: 2009
Journal Articles

Prognostic Factors of Response and Overall Survival (OS) in Higher-Risk MDS (including RAEB-t) Treated with Azacytidine (AZA): Results of the French ATU Program.

Raphael Itzykson, Sylvain Thépot, Bruno Quesnel, Odile Beyne-Rauzy, MD, PhD, Francois Dreyfus, MD, PhD, Norbert Vey, MD, Pascal Turlure, MD, Laurence Legros, Caroline Dartigeas, Jacques Delaunay, MD, Stephane de Botton, MD, PhD, Emmanuel Raffoux, MD, Anne-Laure Taksin, MD, Aspasia Stamatoullas, Anne Marfaing Koka, Eric Wattel, MD, PhD, Sorin Visanica, MD, Célia Salanoubat, Pierre Morel, MD, Pascale Cony Makhoul, Stéphane Cheze, Laurence Sanhes, Isabelle Plantier, Gerard Tertian, Mehdi Dahoun, Agnes Guerci, MD, PhD, Claude Gardin, Lionel Ades, MD, Pierre Fenaux
Journal: Blood
Blood (2009) 114 (22): 3820.
https://doi.org/10.1182/blood.V114.22.3820.3820
Published: 2009
Journal Articles

Treatment of AML with Azacytidine (AZA): Current Results of the French ATU Program.

Claire Fabre, MD, Claude Gardin, MD, Rose-Marie Mbida, Bruno Quesnel, MD, François Dreyfus, MD, Françoise Isnard, MD, Lionel Mannone, MD, Laurence Legros, MD, Thomas Prebet, MD, Norbert Vey, MD, Odile Beyne-Rauzy, MD, Florence Dalbies, MD, Stéphane Cheze, MD, Jacques Delaunay, MD, Christophe Fruchart, MD, Anne Marfaing-Koka, MD, Aspasia Stamatoullas, MD, Dominique Bordessoule, MD, Nathalie Cambier, MD, Jérôme Cornillon, MD, Caroline Dartigeas, MD, Béatrice Delmas-Marsalet, MD, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1849.
https://doi.org/10.1182/blood.V110.11.1849.1849
Published: 2007